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Abstract
Objective: Smartphone apps and mobile devices are an emerging method of healthcare data collection. This study sought to
understand how physicians currently view mobile health (mHealth) technologies and use them in patient care.
Methods: A total of 186 physicians affiliated with Washington University School of Medicine in St. Louis, Missouri, USA
completed a survey in 2016 regarding their current implementation of mHealth technologies for patient care and support
for further development.
Results: More than half of respondents were willing to discuss health apps and mobile devices with patients. However, most
were not currently recommending them to patients. Apps/devices that encouraged a healthy diet and weight or tracked
heart rate received the highest satisfaction ratings. Apps/devices that accessed the EMR (electronic medical record)
remotely, provided medication reminders, or enrolled research subjects garnered the most interest despite respondents
lacking prior experience. A majority agreed that collected biometrics are useful for promoting a healthy lifestyle (68%),
tracking medical treatment (64%), or conducting research (56%); and agreed that proof of accuracy and precision (81%)
and the efficient integration of collected data (68%) are necessary improvements. Uploading data automatically and
updating physicians in real-time was the most preferred method of data integration into the EMR.
Conclusions: Physicians show interest in using mHealth technologies for patient care but have limited experience, usually
with those specific to their specialties. Proof of quality and a method to integrate data into the EMR are necessary for a
mainstream role in healthcare.
Keywords
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Introduction
Widespread use of mobile devices and increasing computing power has spurred the rise of mobile health
(mHealth) technologies such as smartphone applications
and activity trackers.1,2 An underdeveloped opportunity
exists to integrate the unprecedented and accelerating
stream of patient data collected from these technologies
into medical practice.3–6 Devices have been developed to
target various aspects of healthcare, such as encouraging
healthy lifestyles, assisting with diagnoses, and improving patient care following treatment.7–10 When fully realized, mHealth has the potential to reduce costs,
disseminate health information, extend care to

resource-limited settings, and provide continuous information on individual biometrics to precisely diagnose
and intervene in both acute and chronic disease.11–15
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Yet, for physicians, the majority of these mobile
apps and devices remains a novelty. There exists a paucity of guidelines for using the collected data for medical purposes.16 Studies on the effectiveness of apps are
inconsistent and few in number.17–19 The FDA (Food
and Drug Administration) has developed new policies
adapted to the rapid development cycles of medical
software to encourage technological progress while
protecting patients.20,21 Under some of these regulatory
frameworks, clearance is an assurance of safety rather
than a marker of clinical utility.22 Apps with low risk
for patient harm, such as activity trackers, are not
within the FDA’s jurisdiction. Clinicians, as well as
professional societies, are developing their own guidelines.23,24 Security and privacy of patient data remain
an issue.25,26
In addition to these areas of concern, few studies
have explored the perspective of physician adoption
of mHealth technologies. In an interview series of 10
general practitioners in Australia, physicians reported
benefits of mHealth apps including patient education
and health recordkeeping, but the technology was not
integrated into their workflow.27 In a survey of 50 general practitioners in Germany, physicians tended to
support patients using mobile devices to keep track of
medication use, weight, and blood pressure, while they
disapproved of patients using mobile devices to look up
medical information or assist with self-diagnosing.28 In
a survey of 59 healthcare practitioners’ views on directto-consumer mobile teledermoscopy, some respondents
noted the advantages of earlier skin cancer detection,
but the majority were unsure or unconvinced that these
devices should be provided to patients.29 A study on
physicians’ perspectives towards mHealth in Turkey
revealed that an innovation’s perceived serviceability
posed the greatest barrier to its implementation.30
Android and iOS app stores display ratings and
number of downloads, but there is little data on how
many physicians are recommending apps to their
patients and which apps they recommend, if any.
Overall, the perspective of physicians on mHealth technologies has not been well-researched.
To investigate physician attitudes towards the adoption of mHealth technologies, a survey of 1442 healthcare practitioners at Washington University School of
Medicine was conducted to obtain insight into the best
methods of approaching mHealth technologies and
integrating them into medical practice. The survey queried physicians’ experience and satisfaction in using
health apps and wearable devices, methods to integrate
the data into the EMR, current implementation in their
practices, and improvements that would support greater use of information collected by apps/wearables in
their practices.
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Survey results indicate that despite appreciable
interest in mHealth technologies, few physicians recommended them to any of their patients at this time.
Proof of accuracy and precision of the collected biometrics had the most potential to increase physician use
of these technologies.

Methods
The survey titled “Mobile apps and wearable/tracking
devices in healthcare” was generated using Google
Forms (Supplement). The survey was emailed to 1442
health professionals at Washington University School
of Medicine, the majority of whom were physicians.
The email contained a brief description of the study’s
objectives and a link to the survey (Supplement).
Physicians were asked to complete the survey within
23 days and received a reminder email one week
before the deadline. The survey was estimated to take
no longer than 5–10 minutes to complete. The participants completed the survey on their own accord and
remained anonymous. No patient information or personal identifiers were disclosed, and no compensation
was offered to participants.
The first of the three sections of the survey asked
respondents to identify their area of practice, to
describe their medical practice, to estimate the percentage of time dedicated to research, and to estimate the
percentage of time dedicated to clinical practice. The
answer options for each question on this page were
arranged in alphabetic or numeric sequence.
The second section asked respondents for information regarding their experience using mobile apps and
wearable/tracking devices in their medical practice. To
prevent scoring bias favoring items that appear early or
late in a sequence, the order of the health technologies
listed was shuffled across forms such that each respondent received a randomized sequence of apps and devices to evaluate.
The final section asked respondents questions
regarding the implementation of mobile apps and
wearable/tracking devices. Response choices were shuffled except for those following alphabetic or numeric
sequences.
All questions were required to be completed in the
survey except for “Which HEALTH APPS and personal WEARABLES/DEVICES, if any, do you use in
your practice that have NOT been mentioned?” and
for the “Comments” field. All the required questions
on each page of the survey had to be completed before
moving on to the next page.
Survey responses were tabulated onto a Microsoft
Excel document. Microsoft Excel was used for all data
analysis. Only completed surveys were included in the
analysis.
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Results
Of the 1442 potential respondents, 186 physicians completed the survey (12.9% response rate). Table 1
reports the response rate by medical specialty.

Openness to apps and devices
More than half of respondents agreed that they were
open to discussing the use of health apps and wearable/
tracking devices with patients (Table 1). Physicians recognized the potential of these technologies to maintain
and re-establish physical activities. A rheumatologist
stated that for patients with chronic pain syndrome,
increased activity is the single most important predictor
of treatment success. An emergency medicine physician
wrote that of the plethora of disease processes seen in
the ER, many are linked to obesity. A hepatologist
stressed that patients need to maintain or increase
activity prior to liver transplant as well as posttransplantation. Physicians in cardiology and geriatrics
agreed that physical activity needs to be encouraged
through goal-setting and self-motivation. An internist
reported that they counsel patients on daily activity,
and a neurologist wrote that the devices could be
used to ensure return to activity after treatment.
Within the specialties of medical genetics, geriatrics/
nutrition, otolaryngology, and pain medicine, at least
one physician reported recommending apps and devices to 60% or more of their patients. In anesthesiology,
endocrinology, obstetrics/gynecology, pulmonology,
and psychiatry, a few physicians reported recommending health apps to at least 20% of their patients.
However, the majority of physicians reported that
they currently do not recommend these technologies
to any of their patients.

Reported satisfaction with apps and devices
Physicians were asked to express their level of experience, satisfaction and interest towards a variety of
mHealth smartphone applications or personal devices
for patients (Figure 1). Respondents reported the most
experience with “Exercise tracker to measure steps,
range of motion, strength, and/or speed” (38%). The
majority of those with experience using these exercise
trackers in clinical care reported their experience as
“Very satisfied” (30%) or “Somewhat satisfied” (57%).
For each of the other mHealth technologies listed in
the survey, fewer than 20% of physicians reported
prior experience. Respondents expressed highest satisfaction towards “Encouraging weight loss and nutritional eating through calorie counting, activity
tracking, and/or personal emails” and “Heart rate
tracker to record patterns over time.” Respondents
expressed least satisfaction towards “Remote access
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to electronic health record” and “Discussion forum to
post questions to be answered by doctors.”
At least a quarter of physicians responded they were
very interested in the following apps despite lack of
prior experience: “Remote access to electronic health
record,” “Managing medication through dose
reminders, medication diary, refill alerts, and/or drug
interaction info,” “Enrolling research subjects and collecting data,” “Continuous glucose monitor that does
NOT require a finger prick calibration,” “Comparing
medications and finding the lowest price for a prescription,” and “Blood pressure tracker to record readings over time.”
Physicians also reported experience with medical
apps and devices that were not included in the
survey. These included Holter monitors and event
monitors from an emergency medicine physician,
radiograph viewing apps from a radiologist, seizure
trackers from a neurologist, BiliTool from a pediatrician, and an app to track medical events in children
with autism from a psychiatrist. In all, these responses
indicate that apps with diverse functions designed to fit
the clinical needs of specific medical specialties are
available and useful in practice.
While the physicians who participated in the survey
spanned a wide spectrum of medical specialties
(Table 1), the low response numbers within each category did not allow for statistical analyses of differences
across specialties. Of note, physicians did express experience and interest in mHealth technologies outside of
their respective specialties. For example, a home lab
test for infectious diseases garnered a high interest
level in five infectious disease physicians but also in
17 physicians from other specialties, including nephrology, genetics, cardiothoracic surgery, anesthesiology,
and radiology.

Recommending apps and devices to patients
Physicians who already use health apps and devices in
their practice reported mixed approaches for recommending and using these technologies for patient care
(Table 2). At least 10% of respondents endorsed each
of the following schemes: having literature about the
app/device for patients, prescribing the app/device, and
using the app/device during a visit.

Areas of development for apps and devices
The survey also addressed potential improvements that
would facilitate implementation of mHealth technologies (Table 3). A majority of respondents agreed that
data from health apps and wearable/tracking devices
are useful for promoting a healthy lifestyle (68%),
tracking medical treatment (64%), or conducting
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Table 1. Number of respondents recommending mobile health technologies to patients.
Total number
of respondents
Anesthesiology

Open to discussing
apps with patientsa

Recommend apps
to patients

10

4 (40%)

3 (30%)

Cardiology

4

3 (75%)

0 (0%)

Cardiothoracic surgery

3

3 (100%)

0 (0%)

Critical care

1

0 (0%)

0 (0%)

Dermatology

4

1 (25%)

0 (0%)

15

7 (47%)

2 (13%)

Endocrinology

5

5 (100%)

3 (60%)

Gastroenterology

7

3 (43%)

2 (29%)

Genetics

2

1 (50%)

1 (50%)

General surgery

5

4 (80%)

1 (20%)

Geriatrics/nutrition

2

2 (100%)

1 (50%)

Hematology

1

0 (0%)

0 (0%)

Hospice and palliative medicine

1

0 (0%)

0 (0%)

Hospital medicine

13

4 (31%)

2 (15%)

Infectious disease

10

4 (40%)

0 (0%)

Internal medicine – general

1

0 (0%)

1 (100%)

Interventional radiology

2

2 (100%)

0 (0%)

Nephrology

2

1 (50%)

1 (50%)

Neurology

7

3 (43%)

0 (0%)

Neurosurgery

1

1 (100%)

0 (0%)

Obstetrics/gynecology

6

5 (83%)

2 (33%)

Oncology

8

3 (38%)

1 (13%)

Ophthalmology

4

1 (25%)

1 (25%)

Orthopedic surgery

8

3 (38%)

0 (0%)

Otolaryngology

3

3 (100%)

1 (33%)

Pain medicine

1

1 (100%)

1 (100%)

Pathology

1

0 (0%)

0 (0%)

Pediatrics

28

12 (43%)

4 (14%)

Emergency medicine

(continued)
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Table 1. Continued.
Total number
of respondents

Open to discussing
apps with patientsa

Recommend apps
to patients

Physical medicine and rehabilitation

1

1 (100%)

0 (0%)

Plastic surgery

1

0 (0%)

0 (0%)

13

9 (69%)

4 (31%)

Pulmonology

3

2 (67%)

2 (67%)

Radiology

7

4 (57%)

0 (0%)

Rheumatology

2

2 (100%)

0 (0%)

Sleep medicine

2

1 (50%)

1 (50%)

Urology

2

0 (0%)

0 (0%)

95 (51%)

34 (18%)

Psychiatry

Total

186

a

Respondents who indicated “agree” or “strongly agree” to the statement, “I am open to discussing the use of health apps and wearable/tracking devices
with my patients.”
Note: Percentages are of those who responded affirmatively out of the total respondents within each specialty.

research (56%). A significant minority also endorsed
usefulness for making medical diagnoses (28%) or preventing disease (24%). A majority of respondents
agreed that “proof of accuracy and precision” (81%)
and “efficient integration of data collected” (68%) are
valuable directions for improvement.

Data management by EMRs
Challenges for entering the information collected by
mHealth apps and devices into EMRs include transferring data in a timely manner to physicians, standardizing the format of data presentation, and ensuring
patient privacy. The most popular method to achieve
this integration was for applications to automatically
upload data into EMRs via a unique identifier, providing physicians with real-time updates (Table 3).
Respondents also favored a method whereby patients
and physicians use the same application that could be
opened by physicians to view patient data.

Funding for apps and devices
Prices of health apps and devices range from free of
charge to thousands of dollars. The majority of physicians indicated that private insurance (66%) and the
patients themselves (66%) should pay for the apps
and devices (Table 3). Approximately half believed
that Centers for Medicare & Medicaid Services (46%)
should be a payer. Most disagreed that patients’
employers and hospitals should be payers.

Discussion
This survey sought to characterize how physicians
regard and use health apps and wearables/devices for
patients. Their perspectives can guide developers and
manufacturers of apps and devices in creating products
that complement current healthcare practices.
Despite high interest in mHealth technologies, few
physicians were recommending apps/devices to patients
in their practice at the time of the survey. This pattern
of sparse use despite appreciable interest amongst
physicians was evident across nearly all areas of medical practice. On the other hand, the majority of physicians were open to discussing these technologies with
patients and expressed optimism for leveraging
mHealth to promote healthy lifestyles, track treatment,
and conduct research. The age of smartphones has
already changed the way patients and physicians
exchange health data. mHealth technologies can provide longitudinal health guidance, extending the
counseling, assessment, and treatment monitoring for
patients outside of medical facilities.
With the expansion of available health data comes
many challenges.31 Proof of accuracy of the biometrics
collected was the most cited improvement that physicians indicated would increase their use of mHealth
technologies for their patients, according to the
survey. This reflects the consensus that patient protection is of paramount importance. For instance, Roche’s
Accu-Chek Connect diabetes management app was
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Figure 1. Ratings of mobile health technologies for patients by physicians.
For each mHealth app, physicians rated their satisfaction level if they had prior experience with the app or their interest level in learning
more about the app if no prior experience.

Kong et al.

7

Table 2. Ways mobile health technologies are recommended to
patients.
Respondents (%)
Have literature about app/device
for patients

19 (10)

Prescribe the app/device to patients

18 (10)

Use app/device during patient visit

17 (9)

Have app/device in office to
demonstrate to patients

15 (8)

Request for patients to purchase app/
device and return with results

14 (7)

Have device to rent out to patients

3 (2)

recalled by the FDA for miscalculating amounts of
insulin.32 Standardization of biometrics from
mHealth apps and provision of evidence-based guidelines to translate these data into diagnoses and interventions would enhance the use of these technologies
for patient care.17,33 Public platforms such as
AppScript, which allows NHS clinicians to prescribe
apps from the NHS Apps Library, can be a reliable
and up-to-date source of information.34
Furthermore, more information is not always useful.
The onus is on physicians to review the data to make
clinical decisions. In the worst case scenario, signal
fatigue, unreliable data, or transmission delay may
obscure important information and lead to patient
harm.11 The Health Insurance Portability and
Accountability Act (HIPAA) does not extend to patient
data generated outside healthcare settings, and big data
begets concerns about cybersecurity. The recently FDAcleared Airstrip ONE is HIPAA compliant, but this is
an exception to the rule. Studies have found that the
majority of health-related apps on the iOS and
Android marketplaces pose data privacy and security
concerns, including information manipulation and
leaks to third parties.25,26 Finally, another area of development supported by many physicians was a way to
efficiently integrate data from the apps/devices into the
EMR. Physicians prefer to view data in real-time, which
could be achieved if apps automatically upload data into
the EMR. Creators of mHealth technologies should
note the importance of an efficient and secure method
to transfer collected patient data to physicians.
Since the survey results were collected in 2016, the
FDA has adopted new regulations for mHealth

technologies.35 The amended definition of a medical
device in the Food, Drug, and Cosmetic Act excludes
certain medical software functions, including administrative support, lifestyle guides, electronic patient
records, and data display/storage.33 Software providing
clinical decision support or patient decision support
would be evaluated on an individual basis for its potential to cause patient harm.36 Most FDA-cleared medical
apps and wearable devices, including AliveCor,
MobiUS, glucose monitoring systems, and recently the
Airstrip ONE interoperability platform, utilize the 510
(k) pathway, which only requires demonstration of
equivalence to a predicate device on the market. In addition, the new de novo classification process since 2017
allows devices with no legally marketed predicate device
to be designated as Class I or II rather than Class III,
thereby simplifying their review process.37 Since then,
Apple Watch’s EKG and heart rhythm detector have
been granted de novo classification.38 The FDA has
also launched a pre-certification program or streamlined
premarket review, now in its pilot phase.36
This study is limited in that most of survey participants worked at a quaternary care center and major
academic center in the USA, so the results may not be
generalizable to other settings. Private practices and
community hospitals were not sampled. Also, there is
inherent bias in that physicians already interested in
mHealth technology were more likely to respond.
Another limitation is that while this study was aimed
at physicians’ use of mHealth technologies in a professional setting, it is possible that some of the respondents described their experiences with personal use of the
apps. Of note, many of the comments submitted did
support that respondents were describing their experiences using apps and wearables for patient care rather
than for private use.
Since the completion of this survey, mHealth technologies have grown exponentially, heightening the
importance of the results. Appropriate developments
could augment the use of mHealth apps and wearable
devices to achieve higher quality patient care and a more
efficient healthcare system. If these challenges are overcome, mHealth can transform healthcare through ubiquitous interventions for behavioral changes such as
lifestyle practices or treatment adherence, telemedicine,
screening, patient education and access to information,
continuous monitoring of patient conditions, home testing, and medical access for the developing world. This
potential calls for new paradigms to regulate mHealth
technologies, standardized metrics for evaluation,
ensured protection of patient information, and the
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Table 3. Areas of development for apps and devices.
Number of
respondents
What would enhance the likelihood that you would implement information collected by wearable/tracking devices in your practice? a
Proof of accuracy and precision in biometrics collected

151 (81%)

Efficient integration of data collected into the EMR

127 (68%)

Involvement of physicians in developing and/or reviewing devices/apps

80 (43%)

Stringent regulation of how the data collected are stored, used, and shared

70 (38%)

Education to physicians on available devices/apps

69 (37%)

Technology for a single device to collect data on multiple aspects of a patient’s health

61 (33%)

FDA or other centralized regulation of devices/apps

60 (32%)

More patients using the devices/apps

53 (28%)

Please rate the way(s) to collect information from patients’ health apps and wearable/tracking devices from least effective (1) to most effective (5) b
Patients use an application that automatically uploads data into the patient’s electronic medical
record via a unique identifier, providing physicians with real-time updates.

82 (44%)

Patients and physicians use the same application, which physicians open to view patient data.

39 (21%)

Patients sync data from wearable devices to their smartphones and then show data to their
physicians at appointments.

23 (12%)

Patients upload data to a secure online server. Physicians download data from server.

20 (11%)

Patients manually enter data into their charts at appointments.

2 (1%)

How do you think data from health apps and wearable/tracking devices could be used in your practice? a
Promote healthy lifestyle

127 (68%)

Track treatment

119 (64%)

Conduct research

105 (56%)

Make diagnoses

53 (28%)

Prevent disease

45 (24%)

Who should pay for the apps/devices? a

a

Private insurance

122 (66%)

Patient

122 (66%)

Centers for Medicare & Medicaid Services

86 (46%)

Employer

26 (14%)

Hospital

13 (7%)

Physician

2 (1%)

Respondents were asked to choose all that applied.
Number of respondents who rated the method as most effective.
Note: Percentages are of those who selected a given choice out of the total 186 participants of the survey.
b
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bringing together of patients and caregivers, developers,
and physicians to guide progress.

Conclusions
In this online survey of physicians, the majority
reported interest in mHealth apps and wearable devices
for patients, but proof of accuracy and efficient integration of patient-generated data into medical records
are needed before widespread use of these technologies
is attained.
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